Safety, Tolerability and PK of Imeglimin in Japanese Volunteers

NCT02373150 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Imeglimin
DRUG: Placebo

Sponsor

Poxel SA